News

The U.S. Food and Drug Administration (FDA) has granted conditional approval to iberdomide, an oral medication to be used in combination with an antibody-based…

Scientists have developed a new human cell model to study rare cases of cervical cancer that aren’t associated with human papillomavirus (HPV) infection. Few laboratory…

When glucose is scarce, fat cells can produce beta-OHB, a molecule that helps myeloma cells survive metabolic stress, a new study found. The study,…

Treatments using gamma delta T-cells, a type of immune cell, hold promise for treating glioblastoma, scientists said, though they added that much more research is…

An international group of researchers is teaming up to develop a myeloma treatment that harnesses the cancer-killing abilities of natural killer (NK) cells. As…

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the experimental therapy enzomenib (DSP-5336) as a potential treatment for …

More than 40% of patients in a Phase 1 clinical trial of myeloma treatment cevostamab responded to the drug, meaning their cancer burden was…

The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to Eli Lilly’s experimental medication olomorasib as a potential treatment for previously…

Most myeloma patients taking Tecvayli (teclistamab-cqyv) were alive and free from disease progression two years after starting treatment, according to a new analysis…

A large, late-stage clinical trial testing an immunotherapy in people with gynecological cancers is recruiting participants ahead of schedule, even amid the typically slower…